Compositions and methods for use in the treatment of cancer and other indications

TW202629175APending Publication Date: 2026-07-16THERAS INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW114138683
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2024-10-07
Filing Date
2025-10-07
Publication Date
2026-07-16
Patent Text Reader

Abstract

Provided herein are methods of treating diseases, disorders, or conditions including cancers, where the methods comprise administration of Compound 1, or a pharmaceutically acceptable salt thereof, in combination with a CDK inhibitor or a selective estrogen receptor degrader (SERD), as described herein. Such methods may comprise the treatment of cancer, such as breast cancer.
Need to check novelty before this filing date? Find Prior Art